1.
Primary endpoint of fibrinolytic therapy in acute myocardial infarction is
2.
Most common indication of fibrinolytic therapy is
3.
Fibrinolytic agent among the following is
4.
Absolute contraindication for fibrinolytic therapy is
5.
Laboratory test to assess fibrinolytic activity in patients is
6.
The benefit of fibrinolytic therapy in patients with STEMI is well established when administered within ________ hours after symptomatic onset.
7.
Fibrinolytic agent having antigenic property is
8.
Fibrin non-specific fibrinolytic agent is
9.
NOT an absolute contraindication for fibrinolytic therapy is
10.
Following factors increase the risk of stroke when using fibrinolytics, Except
